A phase II study of intensive chemotherapy with fludarabine, cytarabine, and mitoxantrone in P glycoprotein-negative high-risk myelodysplastic syndromes

Publisher Website
Google Scholar
Abstract
Nature - the world's best science and medicine on your desktop